Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-06-01T00:20:43.925Z Has data issue: false hasContentIssue false
  • English
  • Français

Sexual dysfunction in patients with schizophrenia on antipsychotic medication

Published online by Cambridge University Press:  16 April 2020

Alp Üçok ,
Cem İncesu ,
Tamer Aker  and
Şahap Erkoç
Alp Üçok*
Affiliation:
Istanbul University, Istanbul Faculty of Medicine, Department of Psychiatry, Millet Street, Capa 34390, Istanbul, Turkey
Cem İncesu
Affiliation:
Acıbadem Hospital, Department of Psychiatry, Istanbul, Turkey
Tamer Aker
Affiliation:
Kocaeli University, Kocaeli Medical Faculty, Izmit, Turkey
Şahap Erkoç
Affiliation:
Bakırköy State Hospital of Mental Disorders, Istanbul, Turkey
*
*Corresponding author. Tel.: +90 212 4142000; fax: +90 212 5310309. E-mail address: alpucok@superonline.com (A. Ü çok).
Get access

Abstract

Objective

The objective of this study was to determine the prevalence of sexual dysfunction in patients with schizophrenia under antipsychotic therapy and to investigate the effect of various parameters on sexual dysfunction.

Method

A total of 827 stabilized outpatients who met DSM-IV criteria for schizophrenia, were recruited in the study. Arizona Sexual Experience Scale (ASEX) and the subscale on sexual function of the UKU Side Effects Rating Scale were applied at a single interview.

Results

In total, 52.6% of the patients had sexual dysfunction, 54.2% reported a low sexual desire and 41.7% reported problems in having an orgasm. Erectile dysfunction and ejaculation problems were seen in 48.1% and 64.2% of the men, respectively; amenorrhea was seen in 24.9% of the women. ASEX score and severity of disease were found to be correlated (p = 0.02). Higher ASEX scores were observed in patients who smoked (p = 0.01). Men receiving atypical monotherapy had lower ASEX scores than those receiving a combination of atypical and conventional antipsychotics (p = 0.017). Patients on combination therapy had more ejaculation problems than the atypical group (p = 0.001). Low sexual desire was more prevalent among women using conventional drugs than those on atypical drugs (p = 0.004). In linear regression analyses, ASEX was affected significantly and independently by the severity of the disease only in men (p = 0.005).

Conclusion

Our results show that sexual dysfunction is widespread among patients with schizophrenia on antipsychotic medications.

Keywords

SchizophreniaSexual dysfunctionTypical antipsychoticsAtypical antipsychoticsASEX
Type
Original article
Information
European Psychiatry , Volume 22 , Issue 5 , July 2007 , pp. 328 - 333
Copyright
Copyright © Elsevier Masson SAS 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aizenberg, D., Modai, I., Landa, A., Gil-Ad, I., Weizman, A.Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 2001;62:541–544.CrossRefGoogle ScholarPubMed
Aizenberg, D., Zemishlany, Z., Dorfman-Etrog, P., Weizman, A.Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995;56:137–141.Google ScholarPubMed
Alptekin, K., Erkoc, S., Gogus, A.K., Kultur, S., Mete, L., Ucok, A.et al.Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up. Psychiatry Res 2005;135:103–111.CrossRefGoogle ScholarPubMed
Atmaca, M., Kuloglu, M., Tezcan, E.A new atypical antipsychotic: quetiapine-induced sexual dysfunctions. Int J Impot Res 2005;17:201–203.CrossRefGoogle ScholarPubMed
Balon, R.Sexual function and dysfunction during treatment with psychotropic medications. J Clin Psychiatry 2005;66:1488–1499.CrossRefGoogle ScholarPubMed
Bobes, J., Garc A-Portilla, M.P., Rejas, J., Hernandez, G., Garcia-Garcia, M., Rico-Villademoros, F.et al.Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 2003;29:125–147.CrossRefGoogle ScholarPubMed
Byerly, M.J., Lescouflair, E., Weber, M.T., Bugno, R.M., Fisher, R., Carmody, T.et al.An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction. J Sex Marital Ther 2004;30:325–332.CrossRefGoogle ScholarPubMed
Byerly, M.J., Nakonezny, P.A., Bettcher, B.M., Carmody, T., Fisher, R., Rush, A.J.Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophr Res 2006;86:244–250.CrossRefGoogle ScholarPubMed
Byerly, M.J., Nakonezny, P.A., Fisher, R., Magouirk, B., Rush, A.J.An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 2006;81:311–316.CrossRefGoogle Scholar
Cutler, A.J.Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 2003;1(Suppl):69–82.CrossRefGoogle Scholar
Dossenbach, M., Dyachkova, Y., Pirildar, S., Anders, M., Khalil, A., Araszkiewicz, A.et al.Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006;21:251–258.CrossRefGoogle ScholarPubMed
Dossenbach, M., Erol, A., el Mahfoud Kessaci, M., Shaheen, M.O., Sunbol, M.M., Boland, J.et al.IC-SOHO Study Group Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. J Clin Psychiatry 2004;65:312–321.CrossRefGoogle Scholar
Gades, N.M., Nehra, A., Jacobson, D.J., McGree, M.E., Girman, C.J., Rhodes, T.et al.Association between smoking and erectile dysfunction: a population-based study. Am J Epidemiol 2005;161:346–351.CrossRefGoogle ScholarPubMed
Goodnick, P.J., Rodriguez, L., Santana, O.Antipsychotics: impact on prolactin levels. Expert Opin Pharmacoter 2002;3:1381–1391.CrossRefGoogle ScholarPubMed
Guy, W (ed). Clinical global impressions (CGI). In: ECDEU assessment manual for psychopharmacology. US Department of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research branch; 1976. p. 218–22.Google Scholar
Hummer, M., Kemmler, G., Kurz, M., Kurzthaler, I., Oberbauer, H., Fleischhacker, W.W.Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999;156:631–633.Google Scholar
Jayaram, M.B., Hosalli, P.Risperidone versus olanzapine for schizophrenia. Cochrane Database Syst Rev 2005;18(2). CD005237.Google Scholar
Kelly, D.L., Conley, R.R.Sexuality and schizophrenia: a review. Schizophr Bull 2004;30:767–779.CrossRefGoogle ScholarPubMed
Kim, K.S., Pae, C.U., Chae, J.H., Bahk, W.M., Jun, T.Y., Kim, D.J.et al.Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry 2002;63:408–413.CrossRefGoogle ScholarPubMed
Kleinberg, D.L., Davis, J.M., de Coster, R., Van Baelen, B., Brecher, M.Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999;19:57–61.CrossRefGoogle ScholarPubMed
Knegtering, H., Boks, M., Blijd, C., Castelein, S., van den Bosch, R.J., Wiersma, D.A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 2006;32:315–326.CrossRefGoogle ScholarPubMed
Knegtering, R., Castelein, S., Bous, H., Van Der Linde, J., Bruggeman, R., Kluiter, H.et al.A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol 2004;24:56–61.CrossRefGoogle ScholarPubMed
Kockott, G., Pfeiffer, W.Sexual disorders in nonacute psychiatric outpatients. Compr Psychiatry 1996;37:56–61.CrossRefGoogle ScholarPubMed
Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S.et al.Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 2004;19:415–422.CrossRefGoogle ScholarPubMed
Lambert, M., Haro, J.M., Novick, D., Edgell, E.T., Kennedy, L., Ratcliffe, M.et al.Olanzapine vs other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand 2005;111:232–243.CrossRefGoogle ScholarPubMed
Lingjaerde, O., Ahlfors, U.G., Bech, P., Dencker, S.J., Elgen, K.The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987;334(Suppl.):1–100.CrossRefGoogle Scholar
Macdonald, S., Halliday, J., MacEwan, T., Sharkey, V., Farrington, S., Wall, S.et al.Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case–control study. Br J Psychiatry 2003;182:50–56.CrossRefGoogle ScholarPubMed
McGahuey, C.A., Gelenberg, A.J., Laukes, J.A., Moreno, F.A., Delgado, P.L., McKnight, K.M.et al.The Arizona Sexual Experience Scale (ASEX). Reliability and validity. J Sex Marital Ther 2000;26:25–40.Google ScholarPubMed
Montejo Gonzalez, A.L., Rico-Villademoros, F., Tafalla, M., Majadas, S.Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. A 6-month prospective observational study on the effects of quetiapine on sexual functioning J Clin Psychopharmacol 2005;25:533–538.Google Scholar
Naber, D., Karow, A., Lambert, M.Subjective well-being under the neuroleptic treatment and its relevance for compliance. Acta Psychiatr Scand Suppl 2005;427:29–34.CrossRefGoogle Scholar
Olfson, M., Uttaro, T., Carson, W.H., Tafesse, E.Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry 2005;66:331–338.CrossRefGoogle Scholar
Perkins, D.O.Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002;63:1121–1128.CrossRefGoogle ScholarPubMed
Salokangas, R.K., Honkonen, T., Stengard, E., Koivisto, A.M., Hietala, J.Cigarette smoking in long-term schizophrenia. Eur Psychiatry 2006;2:219–223.CrossRefGoogle Scholar
Smith, S.M., O'Keane, V., Murray, R.Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002;181:49–55.CrossRefGoogle ScholarPubMed
Stimmel, G.L., Gutierrez, M.A.Sexual dysfunction and psychotropic medications. CNS Spectr 118 Suppl. 92006 24–30.CrossRefGoogle ScholarPubMed
Teusch, L., Scherbaum, N., Bohme, H., Bender, S., Eschmann-Mehl, G., Gastpar, M.Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995;28:84–92.CrossRefGoogle ScholarPubMed
Ucok, A., Polat, A., Bozkurt, O., Meteris, H.Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry Clin Neurosci 2004;58:434–437.CrossRefGoogle ScholarPubMed
Volavka, J., Czobor, P., Cooper, T.B., Sheitman, B., Lindenmayer, J.P., Citrome, L.et al.Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry 2004;65:57–61.CrossRefGoogle ScholarPubMed
Zhong, K.X., Sweitzer, D.E., Hamer, R.M., Lieberman, J.A.Comparison of quetiapine and risperidone in the treatment of schizophrenia: a randomized, double-blind, flexible-dose, 8-week study. J Clin Psychiatry 2006;67:1093–1103.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.